Evidence map›Paper›PMID 39461858›Full record

ArticleBMJ open2024

Urinary tract infections and associated factors among patients with an enlarged prostate at a tertiary hospital, Dar es Salaam, Tanzania: a hospital-based cross-sectional study.

Elieshiupendo M Niccodem, Mtebe Majigo, Obadia Venance Nyongole, Joel Manyahi, Aminiel Shangali, Anthon George Mwingwa, Peter P Kunambi, Eligius Lyamuya, Agricola Joachim

Abstract read
In one paragraph

Article in BMJ open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Elieshiupendo M NiccodemDepartment of Microbiology and Immunology, Kilimanjaro Christian Medical University College, Moshi, Kilimanjaro, Tanzania, United Republic of eshimankamike137@gmail.com.ORCID http://orcid.org/0000-0001-6469-779X
Mtebe MajigoDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0003-3726-2816
Obadia Venance NyongoleSurgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0002-9807-1960
Joel ManyahiDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0002-1388-3901
Aminiel ShangaliDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0002-3387-6514
Anthon George MwingwaDepartment of Microbiology and Immunology, Kilimanjaro Christian Medical Centre, Moshi, Tanzania, United Republic of.ORCID http://orcid.org/0000-0001-7218-9947
Peter P KunambiMuhimbili University of Health and Allied Sciences, Dar es Salaam, Dar es Salaam, Tanzania, United Republic of.
Eligius LyamuyaDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0002-0136-2826
Agricola JoachimDepartment of Microbiology and Immunology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania, United Republic of.ORCID http://orcid.org/0000-0002-1024-8072

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe objectives are to determine the prevalence of urinary tract infection (UTI) and associated factors among patients diagnosed with benign prostatic hyperplasia and prostate cancer.

designHospital-based cross-sectional study. SETTINGS: Urology clinic and urology ward at Muhimbili National Hospital, which is the main tertiary hospital in Tanzania's largest city.

participantsPatients with benign prostate hyperplasia and prostate cancer presenting with genitourinary symptoms.

main outcome measureThe primary outcome was the occurrence of UTI and factors associated with UTI in patients with benign prostatic hyperplasia and prostate cancer.

results402 participants were enrolled, with a median age of 68 years and IQR of 61-75 years. The proportion of UTI was 46.5% (95% CI 41.56% to 51.53%). UTI was more prevalent among inpatients, patients with indwelling urinary catheters, patients with prostate size>80 cm

conclusionAlmost half of the patients with an enlarged prostate and genitourinary symptoms had a laboratory-confirmed UTI. The risk of UTI increases with age, incomplete bladder emptying and increased duration of catheterisation. A 1-day increase in the duration of catheterisation increased the risk of UTI by 24%.

Indexed as

Prostatic HyperplasiaTertiary Care CentersUrinary Tract InfectionsAgedCross-Sectional StudiesHumansMaleMiddle AgedPrevalenceProstateProstatic NeoplasmsRisk FactorsTanzaniaProstate diseaseUrinary incontinencesUrinary tract infections

Identifiers

PMID39461858
PMCPMC11529770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.